606 results on '"Gragnano, Felice"'
Search Results
2. Understanding the role of coronary artery revascularization in patients with left ventricular dysfunction and multivessel disease
3. De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials
4. Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions
5. The hidden bridging of left anterior descending artery
6. A real-world multicenter study on left atrial appendage occlusion: The Italian multi-device experience
7. Management of high and intermediate-high risk pulmonary embolism: A position paper of the Interventional Cardiology Working Group of the Italian Society of Cardiology
8. Balancing Benefits and Risks of Oral Antiplatelet Strategies in patients With Coronary Artery Diseases: An Evolving Issue
9. Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry
10. Timing and modality of complete revascularization in patients presenting with ST-segment elevation myocardial infarction and multivessel coronary artery disease
11. Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology
12. Aspirin-Free Strategies After Complex PCI
13. Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry
14. Monitoring antiplatelet therapy: where are we now?
15. New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia
16. Long-term antithrombotic therapy in patients with atrial fibrillation and PCI: antiplatelets are fired
17. Atherosclerotic Plaque Erosion: Mechanisms, Clinical Implications, and potential therapeutic Strategies – a review
18. Antithrombotic treatment for chronic coronary syndrome: Evidence and future perspectives
19. Therapeutic Considerations with Revascularization in Chronic Kidney Disease: Radial Versus Femoral Arterial Access
20. Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence
21. Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management
22. Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes
23. Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease
24. Lugar de acceso y tipo de anticoagulante en pacientes con síndrome coronario agudo en clase Killip avanzada o con parada cardiaca extrahospitalaria
25. Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale: The FABOLUS FASTER Trial
26. Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis.
27. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and atrial thrombosis: An appraisal of current evidence
28. Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
29. P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift?
30. FLOW trial stopped early due to evidence of renal protection with semaglutide
31. Choice of P2Y12 Inhibitors After Acute Coronary Syndrome
32. Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry)
33. CYP2C19 Genotyping to Risk Stratify Patients After Coronary Stent Implantation: Time for a Personalized Approach?
34. Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease
35. 2023 ESC Guidelines on ACS: what is new in antithrombotic therapy?
36. What is new in the 2023 AHA/ACC Multisociety guideline on Chronic coronary Disease?
37. Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go
38. External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis
39. Impact of using risk scores to guide clinical decisions: Do they make a difference?
40. Antithrombotic Therapy in Patients Taking Oral Anticoagulants and Undergoing Percutaneous Coronary Intervention: Time to Be Bold and Wise
41. Role of dual lipid-lowering therapy in coronary atherosclerosis regression: Evidence from recent studies
42. Inflammation in patients undergoing transcatheter aortic valve implantation: a therapeutic target for the future?
43. Impact of lipoprotein(a) levels on recurrent cardiovascular events in patients with premature coronary artery disease
44. Perioperative care of cardiac patient’s candidate for non-cardiac surgery: a critical appraisal of emergent evidence and international guidelines
45. Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies
46. Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options
47. Severely calcified coronary artery lesions: focus on interventional management
48. Reply
49. MINOCA Associated with a Myocardial Bridge: Pathogenesis, Diagnosis and Treatment
50. Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.